NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,060 | -78.9% | 56,700 | -75.1% | 0.00% | -63.6% |
| Q3 2022 | $483,000 | -8.2% | 228,000 | +16.6% | 0.01% | 0.0% |
| Q2 2022 | $526,000 | -38.3% | 195,500 | -0.5% | 0.01% | -21.4% |
| Q1 2022 | $853,000 | +49.6% | 196,500 | +78.6% | 0.01% | +40.0% |
| Q4 2021 | $570,000 | +104.3% | 110,000 | +141.8% | 0.01% | +100.0% |
| Q3 2021 | $279,000 | -21.2% | 45,500 | +30.0% | 0.01% | -16.7% |
| Q2 2021 | $354,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |